DELCATH SYSTEMS INC (DCTH) Stock Fundamental Analysis
NASDAQ:DCTH - US24661P8077 - Common Stock
11.65 USD
+0.55 (+4.95%)
11.6 USD
-0.05 (-0.43%)
Taking everything into account, DCTH scores 6 out of 10 in our fundamental rating. DCTH was compared to 190 industry peers in the Health Care Equipment & Supplies industry. DCTH has an excellent financial health rating, but there are some minor concerns on its profitability. DCTH is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year DCTH was profitable.
In the past year DCTH had a positive cash flow from operations.
In the past 5 years DCTH always reported negative net income.
In the past 5 years DCTH always reported negative operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 1.91%, DCTH is doing good in the industry, outperforming 75.26% of the companies in the same industry.
DCTH has a better Return On Equity (2.13%) than 75.79% of its industry peers.
DCTH has a better Return On Invested Capital (3.72%) than 72.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.91% | ||
| ROE | 2.13% | ||
| ROIC | 3.72% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 3.18%, DCTH is doing good in the industry, outperforming 74.74% of the companies in the same industry.
Looking at the Operating Margin, with a value of 7.14%, DCTH is in the better half of the industry, outperforming 75.26% of the companies in the same industry.
With an excellent Gross Margin value of 85.86%, DCTH belongs to the best of the industry, outperforming 96.32% of the companies in the same industry.
In the last couple of years the Gross Margin of DCTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.14% | ||
| PM (TTM) | 3.18% | ||
| GM | 85.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
2. Health
2.1 Basic Checks
DCTH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DCTH has been increased compared to 1 year ago.
DCTH has more shares outstanding than it did 5 years ago.
There is no outstanding debt for DCTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
DCTH has an Altman-Z score of 16.04. This indicates that DCTH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of DCTH (16.04) is better than 94.74% of its industry peers.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.04 |
ROIC/WACC0.42
WACC8.87%
2.3 Liquidity
DCTH has a Current Ratio of 10.88. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH has a better Current ratio (10.88) than 94.74% of its industry peers.
DCTH has a Quick Ratio of 9.87. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH has a Quick ratio of 9.87. This is amongst the best in the industry. DCTH outperforms 93.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.88 | ||
| Quick Ratio | 9.87 |
3. Growth
3.1 Past
DCTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.96%, which is quite impressive.
The Revenue has grown by 491.54% in the past year. This is a very strong growth!
The Revenue has been growing by 88.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)101.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.58%
Revenue 1Y (TTM)491.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%211.05%
3.2 Future
The Earnings Per Share is expected to grow by 31.35% on average over the next years. This is a very strong growth
Based on estimates for the next years, DCTH will show a very strong growth in Revenue. The Revenue will grow by 44.35% on average per year.
EPS Next Y99.11%
EPS Next 2Y58.05%
EPS Next 3Y43.83%
EPS Next 5Y31.35%
Revenue Next Year163.5%
Revenue Next 2Y92.91%
Revenue Next 3Y67.12%
Revenue Next 5Y44.35%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 233.00 indicates a quite expensive valuation of DCTH.
Compared to the rest of the industry, the Price/Earnings ratio of DCTH indicates a somewhat cheap valuation: DCTH is cheaper than 64.21% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.06. DCTH is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 23.87, the valuation of DCTH can be described as rather expensive.
75.79% of the companies in the same industry are more expensive than DCTH, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DCTH to the average of the S&P500 Index (22.69), we can say DCTH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 233 | ||
| Fwd PE | 23.87 |
4.2 Price Multiples
65.79% of the companies in the same industry are more expensive than DCTH, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCTH indicates a somewhat cheap valuation: DCTH is cheaper than 69.47% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 105.38 | ||
| EV/EBITDA | 54.06 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as DCTH's earnings are expected to grow with 43.83% in the coming years.
PEG (NY)2.35
PEG (5Y)N/A
EPS Next 2Y58.05%
EPS Next 3Y43.83%
5. Dividend
5.1 Amount
DCTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
11.65
+0.55 (+4.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners43.89%
Inst Owner Change25.07%
Ins Owners2.73%
Ins Owner Change1.29%
Market Cap407.52M
Analysts84.62
Price Target25.84 (121.8%)
Short Float %8.9%
Short Ratio3.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)135.29%
Min EPS beat(2)96.08%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)-22.09%
Min EPS beat(4)-488.34%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-27.41%
EPS beat(12)6
Avg EPS beat(12)-22.87%
EPS beat(16)8
Avg EPS beat(16)-16.26%
Revenue beat(2)2
Avg Revenue beat(2)9.49%
Min Revenue beat(2)3.72%
Max Revenue beat(2)15.26%
Revenue beat(4)4
Avg Revenue beat(4)7.85%
Min Revenue beat(4)3.72%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)9.82%
Revenue beat(12)7
Avg Revenue beat(12)1.26%
Revenue beat(16)11
Avg Revenue beat(16)26.75%
PT rev (1m)5.56%
PT rev (3m)12.59%
EPS NQ rev (1m)29.05%
EPS NQ rev (3m)-46.98%
EPS NY rev (1m)-71.4%
EPS NY rev (3m)-109.96%
Revenue NQ rev (1m)-2.42%
Revenue NQ rev (3m)12.77%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)7.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 233 | ||
| Fwd PE | 23.87 | ||
| P/S | 5.8 | ||
| P/FCF | 105.38 | ||
| P/OCF | 84.02 | ||
| P/B | 3.88 | ||
| P/tB | 3.88 | ||
| EV/EBITDA | 54.06 |
EPS(TTM)0.05
EY0.43%
EPS(NY)0.49
Fwd EY4.19%
FCF(TTM)0.11
FCFY0.95%
OCF(TTM)0.14
OCFY1.19%
SpS2.01
BVpS3
TBVpS3
PEG (NY)2.35
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.91% | ||
| ROE | 2.13% | ||
| ROCE | 4.71% | ||
| ROIC | 3.72% | ||
| ROICexc | 15.57% | ||
| ROICexgc | 15.57% | ||
| OM | 7.14% | ||
| PM (TTM) | 3.18% | ||
| GM | 85.86% | ||
| FCFM | 5.51% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
F-Score8
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 592.17% | ||
| Cap/Sales | 1.4% | ||
| Interest Coverage | 5.82 | ||
| Cash Conversion | 93.67% | ||
| Profit Quality | 173.25% | ||
| Current Ratio | 10.88 | ||
| Quick Ratio | 9.87 | ||
| Altman-Z | 16.04 |
F-Score8
WACC8.87%
ROIC/WACC0.42
Cap/Depr(3y)208.01%
Cap/Depr(5y)235.23%
Cap/Sales(3y)4.01%
Cap/Sales(5y)12.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.58%
EPS Next Y99.11%
EPS Next 2Y58.05%
EPS Next 3Y43.83%
EPS Next 5Y31.35%
Revenue 1Y (TTM)491.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%211.05%
Revenue Next Year163.5%
Revenue Next 2Y92.91%
Revenue Next 3Y67.12%
Revenue Next 5Y44.35%
EBIT growth 1Y113.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.16%
EBIT Next 3Y84.35%
EBIT Next 5YN/A
FCF growth 1Y114.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.34%
OCF growth 3YN/A
OCF growth 5YN/A